D. Bellows, N. Chan, John J. Chen, Hui-Chen Cheng, P. Macintosh, J. N. Nij Bijvank, M. Vaphiades, K. Weber, S. Wong
{"title":"神经眼科文献综述","authors":"D. Bellows, N. Chan, John J. Chen, Hui-Chen Cheng, P. Macintosh, J. N. Nij Bijvank, M. Vaphiades, K. Weber, S. Wong","doi":"10.1080/01658107.2019.1680181","DOIUrl":null,"url":null,"abstract":"Neuro-Ophthalmic Literature Review David Bellows, Noel Chan, John Chen, Hui-Chen Cheng, Peter MacIntosh, Jenny Nij Bijvank, Michael Vaphiades, Konrad Weber, and Sui Wong “It don’t matter if you’re Black or White” Gruener AM, Poostchi A, Carey AR, Eberhart CG, Henderson AD, Chang JR, McCulley TJ. Association of giant cell arteritis with race. JAMA Ophthalmol. 2019 Aug 8. Giant cell arteritis (GCA) has widely been considered a rare disorder in black patients. In this retrospective study, the authors reviewed the charts of all patients who underwent temporal artery biopsy over a 10-year period (2007 through 2017) at Johns Hopkins School of Medicine. It should be noted that the population of Baltimore is more than 60% black and the patient population at Johns Hopkins is approximately 40% black. For the purposes of this study, a patient’s race was determined by their self-identified race in the electronic medical record. Additionally, only patients over the age of 50 were included to avoid controversy surrounding the diagnosis of giant cell arteritis in younger individuals. A total of 586 patients were identified who had undergone temporal artery biopsy during the study period. Among these patients, 65.2% were white and 28.5% were black. Biopsies that demonstrated active or healed arteritis were considered positive. Using these criteria, 16.1% of the patients were considered to have biopsy-proven giant cell arteritis (BP-GCA); 14 were black (8.4% of all black patients tested) and 75 were white (19.6% of all white patients tested). This translates to a population-adjusted rate of GCA to be 3.1 in blacks and 3.6 in whites per 100,000. The mean age of patients with BP-GCA was similar between the two groups (74.1 years for whites and 75.4 years for blacks) which is consistent with previous reports. Giant cell arteritis has long been thought to have a much greater incidence in whites than in blacks. This widely held belief may cause the clinician to have a higher threshold for obtaining temporal artery biopsy in black patients. In this study, the authors have clearly contradicted that belief. They emphasise the fact that we should have a similar threshold for obtaining temporal artery biopsy regardless of the patient’s race.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":"13 1","pages":"428 - 434"},"PeriodicalIF":0.8000,"publicationDate":"2019-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Neuro-Ophthalmic Literature Review\",\"authors\":\"D. Bellows, N. Chan, John J. Chen, Hui-Chen Cheng, P. Macintosh, J. N. Nij Bijvank, M. Vaphiades, K. Weber, S. Wong\",\"doi\":\"10.1080/01658107.2019.1680181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Neuro-Ophthalmic Literature Review David Bellows, Noel Chan, John Chen, Hui-Chen Cheng, Peter MacIntosh, Jenny Nij Bijvank, Michael Vaphiades, Konrad Weber, and Sui Wong “It don’t matter if you’re Black or White” Gruener AM, Poostchi A, Carey AR, Eberhart CG, Henderson AD, Chang JR, McCulley TJ. Association of giant cell arteritis with race. JAMA Ophthalmol. 2019 Aug 8. Giant cell arteritis (GCA) has widely been considered a rare disorder in black patients. In this retrospective study, the authors reviewed the charts of all patients who underwent temporal artery biopsy over a 10-year period (2007 through 2017) at Johns Hopkins School of Medicine. It should be noted that the population of Baltimore is more than 60% black and the patient population at Johns Hopkins is approximately 40% black. For the purposes of this study, a patient’s race was determined by their self-identified race in the electronic medical record. Additionally, only patients over the age of 50 were included to avoid controversy surrounding the diagnosis of giant cell arteritis in younger individuals. A total of 586 patients were identified who had undergone temporal artery biopsy during the study period. Among these patients, 65.2% were white and 28.5% were black. Biopsies that demonstrated active or healed arteritis were considered positive. Using these criteria, 16.1% of the patients were considered to have biopsy-proven giant cell arteritis (BP-GCA); 14 were black (8.4% of all black patients tested) and 75 were white (19.6% of all white patients tested). This translates to a population-adjusted rate of GCA to be 3.1 in blacks and 3.6 in whites per 100,000. The mean age of patients with BP-GCA was similar between the two groups (74.1 years for whites and 75.4 years for blacks) which is consistent with previous reports. Giant cell arteritis has long been thought to have a much greater incidence in whites than in blacks. This widely held belief may cause the clinician to have a higher threshold for obtaining temporal artery biopsy in black patients. In this study, the authors have clearly contradicted that belief. They emphasise the fact that we should have a similar threshold for obtaining temporal artery biopsy regardless of the patient’s race.\",\"PeriodicalId\":19257,\"journal\":{\"name\":\"Neuro-Ophthalmology\",\"volume\":\"13 1\",\"pages\":\"428 - 434\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2019-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/01658107.2019.1680181\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/01658107.2019.1680181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
神经眼科文献综述David Bellows, Noel Chan, John Chen, Hui-Chen Cheng, Peter MacIntosh, Jenny Nij Bijvank, Michael Vaphiades, Konrad Weber和Sui Wong“无论你是黑人还是白人”巨细胞动脉炎与种族的关系。2019年8月8日。巨细胞动脉炎(GCA)被广泛认为是黑人患者中一种罕见的疾病。在这项回顾性研究中,作者回顾了约翰霍普金斯医学院10年间(2007年至2017年)所有接受颞动脉活检的患者的图表。值得注意的是,巴尔的摩的黑人人口超过60%,约翰霍普金斯大学的患者人口约有40%是黑人。为了本研究的目的,病人的种族是通过他们在电子病历中自我认定的种族来确定的。此外,仅包括50岁以上的患者,以避免围绕年轻人巨细胞动脉炎诊断的争议。在研究期间,共有586名患者接受了颞动脉活检。其中白人占65.2%,黑人占28.5%。活组织检查显示活跃或愈合的动脉炎被认为是阳性的。根据这些标准,16.1%的患者被认为是活检证实的巨细胞动脉炎(BP-GCA);14名黑人(占所有黑人患者的8.4%)和75名白人(占所有白人患者的19.6%)。这意味着,经人口调整后的GCA发病率为每10万人中黑人3.1例,白人3.6例。两组BP-GCA患者的平均年龄相似(白人74.1岁,黑人75.4岁),这与之前的报道一致。巨细胞动脉炎在白人中的发病率一直被认为比黑人高得多。这种广泛持有的信念可能会导致临床医生对黑人患者进行颞动脉活检的门槛更高。在这项研究中,作者明确反驳了这种观点。他们强调,无论患者的种族如何,我们都应该有一个相似的颞动脉活检阈值。
Neuro-Ophthalmic Literature Review David Bellows, Noel Chan, John Chen, Hui-Chen Cheng, Peter MacIntosh, Jenny Nij Bijvank, Michael Vaphiades, Konrad Weber, and Sui Wong “It don’t matter if you’re Black or White” Gruener AM, Poostchi A, Carey AR, Eberhart CG, Henderson AD, Chang JR, McCulley TJ. Association of giant cell arteritis with race. JAMA Ophthalmol. 2019 Aug 8. Giant cell arteritis (GCA) has widely been considered a rare disorder in black patients. In this retrospective study, the authors reviewed the charts of all patients who underwent temporal artery biopsy over a 10-year period (2007 through 2017) at Johns Hopkins School of Medicine. It should be noted that the population of Baltimore is more than 60% black and the patient population at Johns Hopkins is approximately 40% black. For the purposes of this study, a patient’s race was determined by their self-identified race in the electronic medical record. Additionally, only patients over the age of 50 were included to avoid controversy surrounding the diagnosis of giant cell arteritis in younger individuals. A total of 586 patients were identified who had undergone temporal artery biopsy during the study period. Among these patients, 65.2% were white and 28.5% were black. Biopsies that demonstrated active or healed arteritis were considered positive. Using these criteria, 16.1% of the patients were considered to have biopsy-proven giant cell arteritis (BP-GCA); 14 were black (8.4% of all black patients tested) and 75 were white (19.6% of all white patients tested). This translates to a population-adjusted rate of GCA to be 3.1 in blacks and 3.6 in whites per 100,000. The mean age of patients with BP-GCA was similar between the two groups (74.1 years for whites and 75.4 years for blacks) which is consistent with previous reports. Giant cell arteritis has long been thought to have a much greater incidence in whites than in blacks. This widely held belief may cause the clinician to have a higher threshold for obtaining temporal artery biopsy in black patients. In this study, the authors have clearly contradicted that belief. They emphasise the fact that we should have a similar threshold for obtaining temporal artery biopsy regardless of the patient’s race.
期刊介绍:
Neuro-Ophthalmology publishes original papers on diagnostic methods in neuro-ophthalmology such as perimetry, neuro-imaging and electro-physiology; on the visual system such as the retina, ocular motor system and the pupil; on neuro-ophthalmic aspects of the orbit; and on related fields such as migraine and ocular manifestations of neurological diseases.